Trial intelligence / Profile preview

Allopurinol and Hypertension in African Americans

NCT00241839Phase 3Completed

Sponsor
University of Florida
Start
Aug 2005
Primary completion
May 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of allopurinol in hypertension (HTN), sponsored by University of Florida. Started Aug 2005; status: completed.

02

Drugs

allopurinol
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT00241839.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00241839.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call